Palvella Therapeutics (PVLA) FCF Margin (2014 - 2024)
Palvella Therapeutics (PVLA) reported FCF Margin of 2079.25% for Q1 2024, down 150879.0% year-over-year from N/an in Q2 2023, and down 3192.16% on a QoQ basis from 63.16% in Q3 2023.
Palvella Therapeutics (PVLA) has 11 years of FCF Margin data on file, last reported at 2079.25% in Q1 2024.
- Quarterly FCF Margin fell 150879.0% year-over-year to 2079.25% in Q1 2024, while the trailing twelve-month figure through Sep 2024 was 97.2% (up 22485.0% YoY) and the FY2021 annual result came in at 30.81%, up 13500.0% from the prior year.
- FCF Margin retreated to 2079.25% in Q1 2024 per PVLA's latest filing, from 63.16% in the prior quarter.
- Across five years, FCF Margin topped out at 1168.39% in Q2 2021 and bottomed at 3408.53% in Q3 2022.
- The 5-year median for FCF Margin is 228.99% (2020), against an average of 514.26%.
- The widest annual swing landed in 2022, when FCF Margin sank 289732 bps; it then jumped 334537 bps in 2023.
- Tracing PVLA's FCF Margin over 5 years: stood at 745.6% in 2020, then jumped by 68 bps to 239.54% in 2021, then slumped by 1323 bps to 3408.53% in 2022, then surged by 98 bps to 63.16% in 2023, then sank by 3192 bps to 2079.25% in 2024.
- Per Business Quant, the three latest PVLA FCF Margin figures stand at 2079.25% (Q1 2024), 63.16% (Q3 2023), and 67.1% (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -2,079.25% |
| Sep 30, 2023 | -63.16% |
| Jun 30, 2023 | -67.10% |
| Mar 31, 2023 | -570.45% |
| Sep 30, 2022 | -3,408.53% |
| Jun 30, 2022 | -441.03% |
| Mar 31, 2022 | -208.78% |
| Dec 31, 2021 | -239.54% |
| Sep 30, 2021 | -511.21% |
| Jun 30, 2021 | 1,168.39% |
| Mar 31, 2021 | -93.58% |
| Dec 31, 2020 | -745.60% |
| Sep 30, 2020 | -228.99% |
| Jun 30, 2020 | -96.38% |
| Mar 31, 2020 | -128.63% |
| Dec 31, 2019 | -495.75% |
| Sep 30, 2019 | -85.14% |
| Jun 30, 2019 | -218.79% |
| Mar 31, 2019 | -178.22% |
| Dec 31, 2018 | -1,603.83% |
| Sep 30, 2018 | -175.96% |
| Jun 30, 2018 | -80.25% |
| Mar 31, 2018 | 744.82% |
| Dec 31, 2017 | -30.37% |
| Sep 30, 2017 | 888.97% |
| Jun 30, 2017 | -387.75% |
| Mar 31, 2017 | 1,905.58% |
| Dec 31, 2016 | -255.51% |
| Sep 30, 2016 | -480.69% |
| Jun 30, 2016 | -574.78% |
| Mar 31, 2016 | 157.11% |
| Dec 31, 2015 | 671.79% |
| Sep 30, 2015 | -900.11% |
| Jun 30, 2015 | -1,945.16% |
| Mar 31, 2015 | -1,669.75% |
| Sep 30, 2014 | -74.33% |
| Jun 30, 2014 | -488.65% |